Q3 2024 |
48 |
$265M |
+$12.1M |
-$5.27M |
+$6.85M |
IVW, IVE, SCHZ, IUSB, SPMB
|
13F-HR |
10/21/2024, 04:17 PM |
Q2 2024 |
57 |
$246M |
+$20.9M |
-$17.3M |
+$3.62M |
IVW, IVE, SCHZ, IUSB, SPMB
|
13F-HR |
8/9/2024, 04:48 PM |
Q1 2024 |
60 |
$239M |
+$9.84M |
-$13.2M |
-$3.33M |
IVW, IVE, SCHZ, IUSB, SPMB
|
13F-HR |
4/18/2024, 12:03 PM |
Q4 2023 |
58 |
$232M |
+$29.7M |
-$48.7M |
-$19M |
IVW, IVE, SCHZ, IUSB, SPMB
|
13F-HR |
3/19/2024, 05:03 PM |
Q3 2023 |
55 |
$232M |
+$7.85M |
-$5.6M |
+$2.25M |
IVW, IVE, SCHZ, IUSB, SPMB
|
13F-HR |
11/1/2023, 03:45 PM |
Q2 2023 |
60 |
$240M |
+$38M |
-$36.9M |
+$1.14M |
IVW, IVE, SCHZ, IUSB, SPMB
|
13F-HR |
7/18/2023, 01:00 PM |
Q1 2023 |
69 |
$233M |
+$40M |
-$33.5M |
+$6.52M |
IVE, IVW, SCHZ, IUSB, SPMB
|
13F-HR |
4/26/2023, 02:52 PM |
Q4 2022 |
70 |
$217M |
+$100M |
-$95.2M |
+$4.8M |
IVE, IVW, SCHZ, IUSB, IGSB
|
13F-HR |
2/7/2023, 02:47 PM |
Q3 2022 |
69 |
$200M |
+$21.3M |
-$20.9M |
+$409K |
IGIB, IVE, IEFA, IVW, VMBS
|
13F-HR |
10/28/2022, 11:33 AM |
Q2 2022 |
51 |
$213M |
+$9.86M |
-$8.13M |
+$1.72M |
IGIB, IEFA, IVE, VMBS, TLT
|
13F-HR |
7/22/2022, 01:22 PM |
Q1 2022 |
54 |
$241M |
+$10.6M |
-$6.7M |
+$3.92M |
IGIB, IVE, IEFA, VMBS, TLT
|
13F-HR |
4/20/2022, 03:01 PM |
Q4 2021 |
54 |
$254M |
+$8.4M |
-$1.13M |
+$7.26M |
IGIB, IEFA, IVE, VMBS, IVW
|
13F-HR |
1/31/2022, 02:37 PM |
Q3 2021 |
54 |
$239M |
+$10.4M |
-$1.36M |
+$9.09M |
IGIB, IEFA, IVE, VMBS, TLT
|
13F-HR |
10/29/2021, 12:06 PM |
Q2 2021 |
56 |
$232M |
+$11.5M |
-$4.08M |
+$7.45M |
IGIB, IEFA, IVE, VMBS, IVW
|
13F-HR |
8/6/2021, 07:14 PM |
Q1 2021 |
52 |
$215M |
+$19.6M |
-$2.29M |
+$17.3M |
IGIB, IEFA, IVE, VMBS, IVW
|
13F-HR |
5/12/2021, 12:59 PM |
Q4 2020 |
50 |
$193M |
+$14M |
-$16.2M |
-$2.17M |
IGIB, IEFA, IVE, VMBS, IVW
|
13F-HR |
2/8/2021, 08:12 PM |
Q3 2020 |
48 |
$191M |
+$21.6M |
-$6.78M |
+$14.8M |
IGIB, IEFA, VMBS, IVE, TLT
|
13F-HR |
10/28/2020, 08:46 PM |
Q2 2020 |
23 |
$169M |
+$7.77M |
-$1.97M |
+$5.81M |
IGIB, IEFA, VMBS, IVE, IVW
|
13F-HR |
7/9/2020, 04:08 PM |
Q1 2020 |
23 |
$146M |
+$15.1M |
-$14.7M |
+$414K |
IGIB, IEFA, VMBS, IVE, IVW
|
13F-HR |
5/26/2020, 06:04 PM |
Q4 2019 |
45 |
$165M |
+$3.63M |
-$2.67M |
+$957K |
IGIB, IEFA, IVE, VMBS, IVW
|
13F-HR |
1/27/2020, 05:08 PM |
Q3 2019 |
46 |
$158M |
+$7.39M |
-$1.89M |
+$5.5M |
IGIB, IEFA, IVE, IVW, VMBS
|
13F-HR |
11/5/2019, 03:06 PM |
Q2 2019 |
47 |
$151M |
+$4.1M |
-$2.35M |
+$1.75M |
IGIB, IEFA, IVE, IVW, VMBS
|
13F-HR |
7/29/2019, 10:05 AM |
Q1 2019 |
47 |
$145M |
+$15.3M |
-$10.2M |
+$5.12M |
IGIB, IEFA, IVE, IVW, VMBS
|
13F-HR |
5/13/2019, 04:22 PM |
Q4 2018 |
48 |
$129M |
+$8.45M |
-$3.93M |
+$4.52M |
IGIB, IEFA, IVE, IVW, SCHP
|
13F-HR |
2/5/2019, 10:01 AM |
Q3 2018 |
46 |
$136M |
+$19.5M |
-$936K |
+$18.6M |
IGIB, IEFA, IVE, IVW, SCHP
|
13F-HR |
10/12/2018, 11:27 AM |
Q2 2018 |
44 |
$122M |
+$17.3M |
-$5.7M |
+$11.6M |
IGIB, IEFA, SCHP, IVE, IVW
|
13F-HR |
8/13/2018, 05:56 PM |
Q1 2018 |
48 |
$109M |
+$4.44M |
-$16M |
-$11.6M |
IGIB, SCHP, IEFA, IVE, IVW
|
13F-HR |
5/9/2018, 02:43 PM |
Q4 2017 |
50 |
$124M |
$0 |
$0 |
|
IEFA, SCHP, IVE, IGIB, IVW
|
13F-HR |
2/20/2018, 01:36 PM |